User login
The Consortium of Multiple Sclerosis Centers (CMSC) has announced that the next Certification Examination in Rare Neuroimmunologic Disorders will take place in January 2017. The application deadline is December 1, 2016. Certification in Rare Neuroimmunologic Disorders (CRND) is intended to validate quality and consistent care to those living with rare neuroimmunologic disorders of the central nervous system.
These rare disorders include transverse myelitis, neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, and anti-NMDA receptor encephalitis. All licensed health professionals with a recommended one year of experience in providing services for patients with rare neuroimmunologic disorders are eligible to take the examination.
Those who successfully pass the certification exam will be eligible to use the registered designation CRND after their names and will receive certificates from CMSC.
Additional information about this certification program and examination may be found on the following page on the CMSC website: http://www.mscare.org/page/about_crnd
The Consortium of Multiple Sclerosis Centers (CMSC) has announced that the next Certification Examination in Rare Neuroimmunologic Disorders will take place in January 2017. The application deadline is December 1, 2016. Certification in Rare Neuroimmunologic Disorders (CRND) is intended to validate quality and consistent care to those living with rare neuroimmunologic disorders of the central nervous system.
These rare disorders include transverse myelitis, neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, and anti-NMDA receptor encephalitis. All licensed health professionals with a recommended one year of experience in providing services for patients with rare neuroimmunologic disorders are eligible to take the examination.
Those who successfully pass the certification exam will be eligible to use the registered designation CRND after their names and will receive certificates from CMSC.
Additional information about this certification program and examination may be found on the following page on the CMSC website: http://www.mscare.org/page/about_crnd
The Consortium of Multiple Sclerosis Centers (CMSC) has announced that the next Certification Examination in Rare Neuroimmunologic Disorders will take place in January 2017. The application deadline is December 1, 2016. Certification in Rare Neuroimmunologic Disorders (CRND) is intended to validate quality and consistent care to those living with rare neuroimmunologic disorders of the central nervous system.
These rare disorders include transverse myelitis, neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, and anti-NMDA receptor encephalitis. All licensed health professionals with a recommended one year of experience in providing services for patients with rare neuroimmunologic disorders are eligible to take the examination.
Those who successfully pass the certification exam will be eligible to use the registered designation CRND after their names and will receive certificates from CMSC.
Additional information about this certification program and examination may be found on the following page on the CMSC website: http://www.mscare.org/page/about_crnd